侯鹏 |
1)国家自然科学基金 (2015.1-2018.12, 项目编号:81472622)
2)国家自然科学基金 (2015.1-2017.12, 项目编号:81402340)
3)国家自然科学基金 (2014.1-2017.12, 项目编号:81372217)
4)国家自然科学基金 (2013.1-2016.12, 项目编号:81272933)
5)国家自然科学基金 (2012.1-2014.12, 项目编号:81171969)
6)国家自然科学基金 (2010.1-2012.12, 项目编号:30901459)
7)国家自然科学基金 (2010.1-2012.12, 项目编号:30973372)
8)DNA甲基化分子标记用于胃癌早期诊断及预后分析 (2010-2014, 项目编号: 2010CB933903). 973二级子课题
9)教育部新世纪人才支持计划
10)教育部博士点基金 --- 博导类 (项目编号:20120201110058)
11)教育部留学人员择优项目支持计划
12)西安交通大学青年教师跟踪支持项目,(2010.1-2014.12, 项目编号:08143001)
13)西安交通大学基本科研业务费"学科综合交叉类项目"
14)西安交通大学医学院 985三期队伍建设计划
15)西安交通大学医学部第一附属医院学科带头人启动经费
16)西安交通大学“腾飞”特聘教授配套经费
代表论文(*通讯作者)
1) Hou P, Liu D, Xing M*. The T1790A BRAF mutation (L597Q) in childhood acute lymphoblastic leukemia is a functional oncogene. Leukemia. 2007; 21(10):2216-8. (IF: 10.431)
2) Hou P, Ji M, Ge C, Shen J, Li S, He N, Lu Z*. Detection of methylation of human p16(Ink4a) gene 5'-CpG islands by electrochemical method coupled with linker-PCR. Nucleic Acids Res. 2003; 31(16):e92. (IF: 9.112)
3) Hou P, Liu D, Shan Y, Hu S, Studeman K, Condouris S, Wang Y, Trink A, El-Naggar AK, Tallini G, Vasko V, Xing M*. Genetic alterations and their relationship in the phosphatidylinositol 3-kinase/Akt pathway in thyroid cancer. Clin Cancer Res. 2007; 13(4):1161-70. (IF: 8.722)
4) Hou P*, Chen Z, Ji M, He N, Lu Z*. Real-time PCR assay for ultrasensitive quantification of DNA-binding proteins. Clin Chem. 2007; 53(4):581-6. (IF: 7.911)
5) Hou P, Ji M, Li S, Lu Z*. Microarray-based approach for high-throughput genotyping of single-nucleotide polymorphisms with layer-by-layer dual-color fluorescence hybridization. Clin Chem. 2004; 50(10):1955-7. (IF: 7.911)
6) Shi J, Liu W, Sui F, Lu R, He Q, Yang Q Lv H, Shi B, Hou P*. Frequent amplification of AIB1, a critical oncogene modulating major signaling pathways, is associated with poor survival in gastric cancer. Oncotarget 2015 Apr 29 (IF: 6.359)
7) Wang L, Tian L, Yang Q, Li H, Guan H, Shi B, Hou P*. Sulforaphane inhibits thyroid cancer cell growth and invasiveness through the reactive oxygen species-dependent pathway. Oncotarget. 2015 (In press) (IF: 6.359)
8) Qiang W, Zhao Y, Yang Q, Liu W, Guan H, Lv S, Ji M, Shi B, Hou P*. ZIC1 Is a Putative Tumor Suppressor in Thyroid Cancer by Modulating Major Signaling Pathways and Transcription Factor FOXO3a. J Clin Endocrinol Metab. 2014; 99(7):E1163-72. (IF: 6.209)
9) Cui B, Yang Q, Guan H, Shi B, Hou P*, Ji M. PRIMA-1, a Mutant p53 Reactivator, Restores the Sensitivity of TP53 Mutant-type Thyroid Cancer Cells to the Histone Methylation Inhibitor 3-Deazaneplanocin A (DZNep). J Clin Endocrinol Metab. 2014; 99(6):E962-70. (IF: 6.209)
10) Yang Q, Ji M, Guan H, Shi B, Hou P*. Shikonin Inhibits Thyroid Cancer Cell Growth and Invasiveness through Targeting Major Signaling Pathways. J Clin Endocrinol Metab. 2013; 98(12):E1909-17. (IF: 6.209)
11) Hou P, Bojdani E, Xing M*. Induction of Thyroid Gene Expression and Radioiodine Uptake in Thyroid Cancer Cells by Targeting Major Signaling Pathways. J Clin Endocrinol Metab. 2010; 95(2):820-8. (IF: 6.209)
12) Wang Y#, Hou P#, Yu H, Wang W, Ji M, Zhao S, Yan S, Sun X, Liu D, Shi B, Zhu G, Condouris S, Xing M*. High prevalence and mutual exclusivity of genetic alterations in the phosphatidylinositol-3-kinase/akt pathway in thyroid tumors. J Clin Endocrinol Metab. 2007; 92(6):2387-90. (IF: 6.209) #并列第一作者
其它SCI论文请链接 http://www.ncbi.nlm.nih.gov/pubmed/?term=peng+hou